Vertex Pharmaceuticals
VRTX
VRTX
403 hedge funds and large institutions have $16.8B invested in Vertex Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 156 increasing their positions, 133 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $17.1B → $16.8B (-$266M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
403
Holding in Top 10
6
Calls
$361M
Puts
$210M
Top Buyers
| 1 | +$291M | |
| 2 | +$166M | |
| 3 | +$104M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$81M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$78.7M |
Top Sellers
| 1 | -$247M | |
| 2 | -$203M | |
| 3 | -$164M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$97.8M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$94.1M |